Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria

Published:2006-10 Issue:10 Volume:24 Page:2047-2055
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Bakris George L,Ruilope Luis M,McMorn Stephen O,Weston Wayde M,Heise Mark A,Freed Martin I,Porter Lisa E

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference34 articles.

1. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS);Festa;Circulation,2000

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).;Lancet,1998

3. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64);Adler;Kidney Int,2003

4. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature;Dinneen;Arch Intern Med,1997

5. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease;Stenvinkel;J Ren Nutr,2003

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review;Current Diabetes Reviews;2023-06

2. Urate-lowering drugs in the treatment of gout: The unknown about the known;Rheumatology Science and Practice;2021-12-27

3. Effect of oral antihyperglycemic drugs on purine metabolism;Diabetes mellitus;2021-11-13

4. The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies;Medicina;2021-08-25

5. The forgotten type 2 diabetes mellitus medicine: rosiglitazone;Diabetology International;2021-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3